Thanks for your honest reply. Yes, I think Mark and Steve are an asset. What makes you think Mike isn't don't his very best for FBR? You mentioned COVID, dilution, new money. That is a worry for me as well. Hence, I've always added "Punt with money you can afford". I still have high hopes for FBR. Frankly, I'm giving Mike and even Aiden the benefit of the doubt. I think they are solid people. They, unlike Mark and Steve, are the marketing/commercialisation side of things. The worries you mentioned are all due to that and literally there is nothing they could have done. It seems the relationship between Mark and Mike is very strong. That is a good thing, IMHO, I'm in for the long haul. As I told my wife in 2015, this will take 10 years. Lets see what happens in 2025. I'll also add that according to my prediction war seems inevitable in another 10-20 years time.
- Forums
- ASX - By Stock
- FBR
- If not the Pivacs then WHO?
FBR
fbr ltd
Add to My Watchlist
16.7%
!
0.5¢

If not the Pivacs then WHO?, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $28.44M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.5¢ | $15.49K | 2.783M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
134 | 57827566 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 31171404 | 40 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
128 | 56044243 | 0.005 |
48 | 18016280 | 0.004 |
23 | 13670332 | 0.003 |
9 | 11053500 | 0.002 |
17 | 75571999 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 19115108 | 35 |
0.007 | 13024546 | 29 |
0.008 | 4837167 | 11 |
0.009 | 2275330 | 4 |
0.010 | 1539259 | 6 |
Last trade - 15.59pm 04/07/2025 (20 minute delay) ? |
Featured News
FBR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online